JMJudith A. Miller

Judith A. Miller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Judith A. Miller has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • James W. Scholey

    Division of Nephrology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

    4 shared publications
  • Daniel C. Cattran

    Department of Medicine, University of Toronto, Toronto, Ontario, Canada

    3 shared publications
  • Vesta Lai

    Division of Nephrology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

    3 shared publications
  • John A. Duncan

    Department of Medicine, University of Toronto, Toronto, Ontario, Canada

    2 shared publications
  • Joseph Zimpelmann

    Division of Nephrology, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada

    2 shared publications
  • Kevin D. Burns

    Division of Nephrology, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada

    2 shared publications

Latest Publications

  • Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine

    by David Z.I. Cherney, James W. Scholey, Joyce Zhou, Joseph Zimpelmann, Christopher Kennedy, Kevin D. Burns, Vesta Lai, Judith A. Miller


  • The effect of oral contraceptives on the nitric oxide system and renal function

    by D. Z. I. Cherney, J. W. Scholey, D. C. Cattran, A. K. Kang, J. Zimpelmann, C. Kennedy, V. Lai, K. D. Burns, J. A. Miller

    We have demonstrated that oral contraceptive (OC) users exhibit elevated angiotensin II levels and angiotensin II type 1 receptor expression, indicative of renin-angiotensin system (RAS) activation, yet the renal and systemic consequences are minimal, suggesting that there is increased vasodilatory activity, counteracting the effect of RAS activation. We hypothesized that the nitric oxide (NO) system would be upregulated in OC users and that this would be reflected by a blunted hemodynamic response to l-arginine infusion. All subjects were studied after a 7-day controlled sodium and protein diet. Inulin and para-aminohippurate clearance techniques were used to assess renal function. l-Arginine was infused at 100, 250, and 500 mg/kg, each over 30 min. Skin endothelial NO synthase mRNA expression was assessed by real-time PCR. While OC nonusers exhibited significant increases in effective renal plasma flow (670.8 ± 35.6 to 816.2 ± 59.7 ml·min−1·1.73 m−2) and glomerular filtration rate (133.4 ± 4.3 to 151.0 ± 5.7 ml·min−1·1.73 m−2, P = 0.04) and declines in renal vascular resistance (81.1 ± 6.1 to 63.5 ± 6.2 mmHg·ml−1·min, P = 0.001) at the lower l-arginine infusion rates, the responses in OC users were blunted. While l-arginine reduced mean arterial pressure at the 250 and 500 mg/kg doses in OC nonusers, OC users only exhibited a decrease in mean arterial pressure at the highest infusion rate. In contrast, tissue endothelial NO synthase mRNA levels were higher in the OC users ( P = 0.04). In summary, these findings suggest that the NO system is upregulated by OC use in young, healthy women. Increased activity of the NO pathway may modulate the hemodynamic effects of RAS activation in OC users.


  • Open Access

    Gender Differences in the Renal Response to Renin-Angiotensin System Blockade

    by Judith A. Miller, David Z. Cherney, John A. Duncan, Vesta Lai, Kevin D. Burns, Christopher R.J. Kennedy, Joseph Zimpelmann, Wei Gao, Daniel C. Cattran, James W. Scholey

    Evidence suggests that gender differences exist in renin-angiotensin system (RAS) function. It was hypothesized that women may differ also in their response to RAS blockade. The renal and peripheral hemodynamic responses to incremental dosages of an angiotensin receptor blocker and the degree of angiotensin II (AngII) insensitivity achieved during 8 wk were examined in men and women. Participants were 30 young healthy men (n = 15; mean age 27 ± 2) and women (n = 15; mean age 28 ± 2) who were on a controlled sodium and protein diet for 1 wk before each study. The humoral, renal, and systemic response to incremental dosages of irbesartan (75 mg for 4 wk, then 150 mg for 4 wk) was assessed, as was the pressor response to AngII (3 ng/kg per min), at 2-wk intervals. AngII type 1 receptor expression in skin biopsies was assessed at baseline and after 8 wk by a real-time PCR protocol. Men and women both exhibited significant declines in BP. Women achieved significantly reduced AngII sensitivity compared with men at lower dosages, showing no pressor response at 4 wk of 75 mg/d irbesartan, whereas men continued to exhibit a pressor response at 4 wk of 150 mg/d. Receptor expression at baseline did not differ between men and women but by 8 wk was significantly decreased in women and unchanged in men. Our findings indicate that men may require larger dosages of angiotensin receptor blocker than do women and that the BP response cannot be used as a surrogate marker for adequate RAS blockade of the renal microvasculature.


  • Open Access

    Impact of an Exercise Program on Arterial Stiffness and Insulin Resistance in Hemodialysis Patients

    by Stefan Mustata, Christopher Chan, Vesta Lai, Judith A. Miller

    Cardiovascular disease remains the primary cause of mortality in patients who are maintained on hemodialysis. Arterial stiffness and insulin resistance are independent risk factors for cardiovascular mortality in this population. In healthy individuals, higher physical conditioning is associated with reduced arterial stiffness. Exercise reduces insulin resistance and glucose intolerance in sedentary, overweight individuals and diabetic patients. The purpose of this study was to determine the impact of an exercise program on arterial stiffness and insulin resistance in a group of patients on hemodialysis. The effect of exercise training on arterial stiffness and insulin resistance in 11 patients who were on chronic hemodialysis was evaluated. Exercise classes of 1-h duration were conducted twice weekly for 3 mo. Arterial stiffness was assessed using the radial artery pressure waveform analysis. Aerobic exercise improved arterial stiffness from 17 ± 3 u at baseline to 12.2 ± 3 u at the end of the intervention (P = 0.01). After 1 mo of detraining, arterial stiffness reverted to pre-exercise levels (17.3 ± 3 u). Pulse pressure paralleled arterial stiffness changes, and the correlation between them was statistically significant (r = 0.725, P = 0.012). Insulin resistance was calculated using the homeostatic model assessment formula. Exercise at the intensity and duration used in our study had no impact on insulin resistance (P = 0.38). These findings suggest that 3 mo of aerobic exercise training improves arterial stiffness, an independent risk factor for cardiovascular mortality in patients who are on hemodialysis, and has no impact on insulin resistance. The beneficial effect on arterial stiffness dissipates within 1 mo of detraining. To obtain therapeutic benefits, an exercise program for patients who are maintained on hemodialysis should be designed to promote regular long term exercise, >3 h/wk.


  • The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans

    by Judith A Miller, James W Scholey

    The renin-angiotensin system plays a central role in health and disease but the determinants of renin-angiotensin system activity have not been fully elucidated. Physiologic genomics continues to be an active area of research that emphasizes definition of phenotype and clarification of non-genomic factors that influence the genotype-phenotype correlation. A common variant of the angiotensinogen gene (T235) predicts elevated levels of circulating angiotensinogen, and polymorphisms of this gene have been linked to physiologic responses and to the risk of cardiovascular disease. The angiotensin-converting-enzyme gene insertion/deletion polymorphism, although not considered functional, has been associated with physiologic responses and disease risk in hypertension and diabetes. A polymorphism of the angiotensin type 1 receptor gene, A1166C, has been the focus of several physiologic studies. These authors will focus on mechanistic studies in normal humans and those with diabetes mellitus or hypertension that examine the impact of these polymorphisms on physiologic responses. Recent studies provide divergent results. Many have shown that mediating factors interfere with the genotype-phenotype correlation. Studies in normal individuals and in those with diabetes mellitus have shown that sodium status and glycemia can alter the impact of genotype. In individuals with essential hypertension, the pathway between genotype and physiology can be disrupted by gender and/or race. Divergent results in many studies may be attributable to various non-genomic and environmental influences on the pathway between gene polymorphism and physiology. Clarification of these factors should allow a better understanding of genotype-phenotype correlation.


  • Relationship Between Diurnal Blood Pressure, Renal Hemodynamic Function, and the Renin-Angiotensin System in Type 1 Diabetes

    by Judith A. Miller, Jacqueline R. Curtis, Etienne B. Sochett

    In patients with diabetes, altered diurnal blood pressure (BP) regulation (high night-to-day [N/D] ratio, or “nondipping”) is associated with increases in albumin excretion and a decline in the glomerular filtration rate (GFR) by an unknown mechanism. Because it is known that renin angiotensin system (RAS) activation and defective glucose control contribute to adverse renal outcomes, we examined renal responses to high glucose and to manipulation of the RAS in adolescents (mean age 14 ± 2 years) with uncomplicated type 1 diabetes, segregated into two groups on the basis of the presence or absence of normal N/D BP ratio. In the first experiment, renal hemodynamic comparisons were made during euglycemia (4–6 mmol/l) and hyperglycemia (9–11 mmol/l), maintained by modified clamp techniques. The induction of hyperglycemia resulted in a significant increase in GFR and filtration fraction (FF) in the high N/D ratio group. In the second experiment, we examined the renal response to graded angiotensin II (Ang II) infusion while subjects were euglycemic and salt replete. High N/D ratio was associated with an enhanced FF response to Ang II. In the third experiment, the N/D ratio and GFR were assessed after 3 weeks of ACE inhibition. This maneuver corrected the high N/D ratio, but it had no effect on glomerular hyperfiltration. These results suggest that RAS activation does not explain the hyperfiltration state, nor can it explain the poor outcomes, at least in this population. However, the observed deleterious hemodynamic responses to high glucose and Ang II and the insensitivity to ACE inhibition may, taken together, provide an explanation for the adverse renal outcomes in patients with type 1 diabetes and high N/D ratio.


  • Interactions between gender and the angiotensin type 1 receptor gene polymorphism

    by Heather Reich, John A. Duncan, Jordan Weinstein, Daniel C. Cattran, James W. Scholey, Judith A. Miller


    • 1 February 2003
      • Vol. 26  (1) , 38-44

    Impact of gender on renal disease: the role of the renin angiotensin system.

    by Amrit K Kang, Judith A Miller

    Recent studies have identified key gender differences with respect to cardiovascular function, renal hemodynamics and the renin angiotensin system (RAS). Extensive epidemiologic evidence has shown a clear gender difference associated with progression of cardiovascular and renal disease, whereby female sex appears to be protective. The mechanisms underlying this phenomenon are unknown but likely reflect the aforementioned sex differences in common pathophysiological pathways. This review focuses on studies examining sex differences in renal function, blood pressure and the RAS, which together may provide a plausible mechanism for the gender disparity in clinical outcomes.


  • Effects of gender on the renin-Angiotensin system, blood pressure, and renal function

    by Amrit K. Kang, Judith A. Miller

    Recent studies have identified key gender differences in cardiovascular function, renal hemodynamics, and the renin-angiotensin system. Extensive epidemiologic evidence has shown a clear gender difference in cardiovascular and renal disease progression, whereby female sex appears to be protective. The mechanisms underlying this phenomenon are unknown, but likely reflect the aforementioned sex differences in common pathophysiologic pathways. This review focuses on studies examining sex differences in these underlying pathways, which together may provide a plausible mechanism for the gender disparity in clinical outcomes.


  • Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.

    by J A Miller, K Thai, J W Scholey

    Recent studies suggest that there is an association between the A1166-->C polymorphism of the angiotensin II type 1 receptor (AGT1R), glycemic control, and the risk of diabetic nephropathy in subjects with type 1 diabetes. Because hypertension and renal hemodynamic function are also related to the risk of diabetic nephropathy and because hyperglycemia can activate the renin angiotensin system, we sought to determine if there is an association between the AGT1R polymorphism, baseline renal and peripheral hemodynamic function, and pressor response to high glucose in subjects with early uncomplicated type 1 diabetes. There were 39 diabetic subjects genotyped for the AGT1R polymorphism by polymerase chain reaction and segregated into 2 groups: those with and those without the C1166 allele (AA and AC/CC). The average age was 27 +/- 1 years, and the mean duration of diabetes was 3.5 +/- 0.6 years. HbA(1c) values were C polymorphism and renal hemodynamic function in early type 1 diabetes. But more importantly, the pressor response to hyperglycemia is augmented in those diabetic patients with the C1166 allele and may represent a factor that predisposes them to renal injury during periods of inadequate glucose control.